Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”

Male infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases....

Full description

Bibliographic Details
Main Authors: Evangelos N. Symeonidis, Evangelini Evgeni, Vasileios Palapelas, Dimitra Koumasi, Nikolaos Pyrgidis, Ioannis Sokolakis, Georgios Hatzichristodoulou, Chara Tsiampali, Ioannis Mykoniatis, Athanasios Zachariou, Nikolaos Sofikitis, Ares Kaltsas, Fotios Dimitriadis
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/10/1534
_version_ 1797515472853270528
author Evangelos N. Symeonidis
Evangelini Evgeni
Vasileios Palapelas
Dimitra Koumasi
Nikolaos Pyrgidis
Ioannis Sokolakis
Georgios Hatzichristodoulou
Chara Tsiampali
Ioannis Mykoniatis
Athanasios Zachariou
Nikolaos Sofikitis
Ares Kaltsas
Fotios Dimitriadis
author_facet Evangelos N. Symeonidis
Evangelini Evgeni
Vasileios Palapelas
Dimitra Koumasi
Nikolaos Pyrgidis
Ioannis Sokolakis
Georgios Hatzichristodoulou
Chara Tsiampali
Ioannis Mykoniatis
Athanasios Zachariou
Nikolaos Sofikitis
Ares Kaltsas
Fotios Dimitriadis
author_sort Evangelos N. Symeonidis
collection DOAJ
description Male infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases. Nowadays, urologists are confronted with a wide spectrum of conditions ranging from the typical infertile male to more complex cases of either unexplained or idiopathic male infertility, requiring a specific patient-tailored diagnostic approach and management. Strikingly enough, no identifiable cause in routine workup can be found in 30% to 50% of infertile males. The medical term male oxidative stress infertility (MOSI) was recently coined to describe infertile men with abnormal sperm parameters and oxidative stress (OS), including those previously classified as having idiopathic infertility. OS is a critical component of male infertility, entailing an imbalance between reactive oxygen species (ROS) and antioxidants. ROS abundance has been implicated in sperm abnormalities, while the exact impact on fertilization and pregnancy has long been a subject of considerable debate. In an attempt to counteract the deleterious effects of OS, urologists resorted to antioxidant supplementation. Mounting evidence indicates that indiscriminate consumption of antioxidants has led in some cases to sperm cell damage through a reductive-stress-induced state. The “antioxidant paradox”, one of the biggest andrological challenges, remains a lurking danger that needs to be carefully avoided and thoroughly investigated. For that reason, oxidation-reduction potential (ORP) emerged as a viable ancillary tool to basic semen analysis, measuring the overall balance between oxidants and antioxidants (reductants). A novel biomarker, the Male infertility Oxidative System (MiOXSYS<sup>®</sup>), is a paradigm shift towards that goal, offering a quantification of OS via a quick, reliable, and reproducible measurement of the ORP. Moderation or “<i>Μέτρον</i>” according to the ancient Greeks is the key to successfully safeguarding redox balance, with MiOXSYS<sup>®</sup> earnestly claiming its position as a guarantor of homeostasis in the intracellular redox milieu. In the present paper, we aim to offer a narrative summary of evidence relevant to redox regulation in male reproduction, analyze the impact of OS and reductive stress on sperm function, and shed light on the “antioxidant paradox” phenomenon. Finally, we examine the most up-to-date scientific literature regarding ORP and its measurement by the recently developed MiOXSYS<sup>®</sup> assay.
first_indexed 2024-03-10T06:45:59Z
format Article
id doaj.art-22c1fe259c4448468b317dd2c8eb407e
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T06:45:59Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-22c1fe259c4448468b317dd2c8eb407e2023-11-22T17:15:26ZengMDPI AGAntioxidants2076-39212021-09-011010153410.3390/antiox10101534Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”Evangelos N. Symeonidis0Evangelini Evgeni1Vasileios Palapelas2Dimitra Koumasi3Nikolaos Pyrgidis4Ioannis Sokolakis5Georgios Hatzichristodoulou6Chara Tsiampali7Ioannis Mykoniatis8Athanasios Zachariou9Nikolaos Sofikitis10Ares Kaltsas11Fotios Dimitriadis12Department of Urology, “G. Gennimatas” General Hospital, Aristotle University of Thessaloniki, 54635 Thessaloniki, GreeceCryogonia Cryopreservation Bank, 11526 Athens, Greece3rd Department of Obstetrics and Gynecology, Hippokration General Hospital, School of Medicine, Aristotle University, 54642 Thessaloniki, GreeceCryogonia Cryopreservation Bank, 11526 Athens, GreeceDepartment of Urology, ‘Martha-Maria’ Hospital Nuremberg, 90491 Nuremberg, GermanyDepartment of Urology, ‘Martha-Maria’ Hospital Nuremberg, 90491 Nuremberg, GermanyDepartment of Urology, ‘Martha-Maria’ Hospital Nuremberg, 90491 Nuremberg, GermanyIndependent Researcher, 54250 Thessaloniki, GreeceDepartment of Urology, “G. Gennimatas” General Hospital, Aristotle University of Thessaloniki, 54635 Thessaloniki, GreeceDepartment of Urology, School of Medicine, Ioannina University, 45500 Ioannina, GreeceDepartment of Urology, School of Medicine, Ioannina University, 45500 Ioannina, GreeceDepartment of Urology, School of Medicine, Ioannina University, 45500 Ioannina, GreeceDepartment of Urology, “G. Gennimatas” General Hospital, Aristotle University of Thessaloniki, 54635 Thessaloniki, GreeceMale infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases. Nowadays, urologists are confronted with a wide spectrum of conditions ranging from the typical infertile male to more complex cases of either unexplained or idiopathic male infertility, requiring a specific patient-tailored diagnostic approach and management. Strikingly enough, no identifiable cause in routine workup can be found in 30% to 50% of infertile males. The medical term male oxidative stress infertility (MOSI) was recently coined to describe infertile men with abnormal sperm parameters and oxidative stress (OS), including those previously classified as having idiopathic infertility. OS is a critical component of male infertility, entailing an imbalance between reactive oxygen species (ROS) and antioxidants. ROS abundance has been implicated in sperm abnormalities, while the exact impact on fertilization and pregnancy has long been a subject of considerable debate. In an attempt to counteract the deleterious effects of OS, urologists resorted to antioxidant supplementation. Mounting evidence indicates that indiscriminate consumption of antioxidants has led in some cases to sperm cell damage through a reductive-stress-induced state. The “antioxidant paradox”, one of the biggest andrological challenges, remains a lurking danger that needs to be carefully avoided and thoroughly investigated. For that reason, oxidation-reduction potential (ORP) emerged as a viable ancillary tool to basic semen analysis, measuring the overall balance between oxidants and antioxidants (reductants). A novel biomarker, the Male infertility Oxidative System (MiOXSYS<sup>®</sup>), is a paradigm shift towards that goal, offering a quantification of OS via a quick, reliable, and reproducible measurement of the ORP. Moderation or “<i>Μέτρον</i>” according to the ancient Greeks is the key to successfully safeguarding redox balance, with MiOXSYS<sup>®</sup> earnestly claiming its position as a guarantor of homeostasis in the intracellular redox milieu. In the present paper, we aim to offer a narrative summary of evidence relevant to redox regulation in male reproduction, analyze the impact of OS and reductive stress on sperm function, and shed light on the “antioxidant paradox” phenomenon. Finally, we examine the most up-to-date scientific literature regarding ORP and its measurement by the recently developed MiOXSYS<sup>®</sup> assay.https://www.mdpi.com/2076-3921/10/10/1534male infertilityredox balancereactive oxygen speciesoxidative stressreductive stressantioxidants
spellingShingle Evangelos N. Symeonidis
Evangelini Evgeni
Vasileios Palapelas
Dimitra Koumasi
Nikolaos Pyrgidis
Ioannis Sokolakis
Georgios Hatzichristodoulou
Chara Tsiampali
Ioannis Mykoniatis
Athanasios Zachariou
Nikolaos Sofikitis
Ares Kaltsas
Fotios Dimitriadis
Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
Antioxidants
male infertility
redox balance
reactive oxygen species
oxidative stress
reductive stress
antioxidants
title Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_full Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_fullStr Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_full_unstemmed Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_short Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_sort redox balance in male infertility excellence through moderation μέτρον ἄριστον
topic male infertility
redox balance
reactive oxygen species
oxidative stress
reductive stress
antioxidants
url https://www.mdpi.com/2076-3921/10/10/1534
work_keys_str_mv AT evangelosnsymeonidis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT evangelinievgeni redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT vasileiospalapelas redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT dimitrakoumasi redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT nikolaospyrgidis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT ioannissokolakis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT georgioshatzichristodoulou redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT charatsiampali redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT ioannismykoniatis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT athanasioszachariou redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT nikolaossofikitis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT areskaltsas redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT fotiosdimitriadis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston